"Wegovy is a No": A Comprehensive Look at Olympic Doping and Detection Technology
As the 2026 Milan-Cortina d'Ampezzo Winter Olympics continue, the world of sports is once again focused on the thin line between medical treatment...
Biowatch
Samsung Bioepis Set to Launch Eylea Biosimilar in the U.S. Next January
Samsung Bioepis announced on the 12th that it has entered into a patent license agreement with the original developer regarding its low-dose (2mg)...
DNA in Blood Speaks of Cancer Traces
"Can we detect multiple cancers early with just one blood draw?" As interest grows in diagnostic tests that quickly...
ABL Bio Publishes Review Paper on Dual Antibodies in International Journal
ABL Bio announced on the 11th that it published a review paper on the next-generation immune-oncology dual antibody...
Launch of 'TrumpRX' Sells Drugs at Steep Discounts: Will Celltrion and Samsung Biologics Face Price Pressure?
The prescription drug sales platform 'TrumpRX', named after U. S. President Donald Trump, has officially launched.
LigaChemBio Receives Milestone from Czech Sotio Biotech
LigaChem Biosciences announced on the 9th that it will receive milestone payments based on successful product...
High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval
Since the World Health Organization recommended the use of obesity medications for adults last December, the market is...
Eubiologics Reports Net Profit for Two Consecutive Years, What’s Next?
Cholera vaccine specialist Eubiologics has shown strong performance growth, recording net profits for two consecutive...
Celltrion "Asthma Drug 'Omrilclo' Captures 60% Market Share in Spain"
Celltrion announced on the 4th that its chronic spontaneous urticaria and allergic asthma treatment, 'Omrilclo ', is...
From 8.7 Billion Deficit to 16.3 Billion Surplus: Seers Strikes Gold in the Middle East
"We have been working to penetrate the Middle Eastern market since 2018. The pricing per bed and equipment costs there...